Education
About Us
Working with TipRanks
Follow Us
Eurobio-Scientific SA (FR:ALERS)
:ALERS
RESEARCH TOOLSreports
Total Valuation
Eurobio-Scientific SA has a market cap or net worth of €255.14M. The enterprise value is €63.39M.
Market Cap€255.14M
Enterprise Value€63.39M
Share Statistics
Eurobio-Scientific SA has 10,248,871 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,248,871
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eurobio-Scientific SA’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 3.94%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.94%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee470.97K
Profits Per Employee12.15K
Employee Count329
Asset Turnover0.60
Inventory Turnover3.08
Valuation Ratios
The current PE Ratio of Eurobio-Scientific SA is 64.69. Eurobio-Scientific SA’s PEG ratio is -0.15.
PE Ratio64.69
PS Ratio0.00
PB Ratio1.21
Price to Fair Value1.45
Price to FCF5.34
Price to Operating Cash Flow4.97
PEG Ratio-0.15
Income Statement
In the last 12 months, Eurobio-Scientific SA had revenue of 154.95M and earned 4.00M in profits. Earnings per share was 0.39.
Revenue154.95M
Gross Profit71.95M
Operating Income13.40M
Pretax Income6.30M
Net Income4.00M
EBITDA20.40M
Earnings Per Share (EPS)0.39
Cash Flow
In the last 12 months, operating cash flow was 16.70M and capital expenditures -3.26M, giving a free cash flow of 13.45M billion.
Operating Cash Flow16.70M
Free Cash Flow13.45M
Free Cash Flow per Share1.31
Dividends & Yields
Eurobio-Scientific SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.38
52-Week Price Change76.74%
50-Day Moving Average24.90
200-Day Moving Average25.29
Relative Strength Index (RSI)55.57
Average Volume (3m)1.38K
Important Dates
Eurobio-Scientific SA upcoming earnings date is Oct 14, 2025, TBA Not Confirmed.
Last Earnings DateApr 28, 2025
Next Earnings DateOct 14, 2025
Ex-Dividend Date―
Financial Position
Eurobio-Scientific SA as a current ratio of 2.03, with Debt / Equity ratio of 65.92%
Current Ratio2.03
Quick Ratio1.42
Debt to Market Cap0.11
Net Debt to EBITDA0.60
Interest Coverage Ratio2.39
Taxes
In the past 12 months, Eurobio-Scientific SA has paid 2.30M in taxes.
Income Tax2.30M
Effective Tax Rate0.37
Enterprise Valuation
Eurobio-Scientific SA EV to EBITDA ratio is 13.29, with an EV/FCF ratio of 20.16.
EV to Sales1.75
EV to EBITDA13.29
EV to Free Cash Flow20.16
EV to Operating Cash Flow16.23
Balance Sheet
Eurobio-Scientific SA has €23.07M in cash and marketable securities with €34.05M in debt, giving a net cash position of €10.99M billion.
Cash & Marketable Securities€23.07M
Total Debt€34.05M
Net Cash€10.99M
Net Cash Per Share€1.07
Tangible Book Value Per Share€2.47
Margins
Gross margin is 42.62%, with operating margin of 8.65%, and net profit margin of 2.58%.
Gross Margin42.62%
Operating Margin8.65%
Pretax Margin4.07%
Net Profit Margin2.58%
EBITDA Margin13.17%
EBIT Margin7.74%
Analyst Forecast
The average price target for Eurobio-Scientific SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast19.15%
EPS Growth Forecast-20.71%